Literature DB >> 2342235

The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy.

K Isono1, T Ochiai, K Okuyama, S Onoda.   

Abstract

During the period between 1965 and the end of 1988, 560 patients with esophageal cancer were surgically treated in our University hospital. In an attempt to improve patient survival, three-field lymphadenectomy of the bilateral neck, mediastinum and abdomen was performed in 117 patients treated since 1983. The present study was undertaken to reveal the substantial rate of lymph node metastasis in esophageal cancer and to decide if three-field lymphadenectomy is mandatory or not for surgery of esophageal cancer. Despite the increased radicality of the operation, the mortality and morbidity rates decreased in the 1980's compared to the earlier periods, the operative death being 12.5 per cent in the 1960's, vs. 2.0 per cent in the 1980's. Moreover, the mortality rate of the patients receiving the three-field lymphadenectomy was as low as 2.6 per cent. The metastatic rate of cervical nodes in the patients receiving three-field lymphadenectomy was 32.5 per cent, while that of mediastinal and abdominal nodes was 47.0 per cent and 46.0 per cent respectively. The metastatic rate in the mediastinum was high in the bilateral recurrent nerve lymph nodes, bifurcation nodes and paraesophageal nodes, while in the abdomen, it was high in the bilateral paracardial nodes. Recurrent nerve paralysis, which had been rarely seen was observed in 12.0 per cent of the patients. Metastasis from esophageal cancer is often seen in the cervical nodes, however, the clinical importance of three-field lymphadenectomy will be decided by the data of patient survival in the near future.

Entities:  

Mesh:

Year:  1990        PMID: 2342235     DOI: 10.1007/bf02470762

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  5 in total

1.  Left thoracotomy approach for resection of carcinoma of the esophagus.

Authors:  G N Pradhan; J B Eng; S Sabanathan
Journal:  Surg Gynecol Obstet       Date:  1989-01

2.  Guide lines for the clinical and pathologic studies on carcinoma of the esophagus.

Authors: 
Journal:  Jpn J Surg       Date:  1976-06

3.  Transthoracic resection of esophageal cancer in patients with pulmonary dysfunction. Usefulness of high frequency ventilation during thoracotomy.

Authors:  M Imamura; K Yanagibashi; T Tobe; Y Shimada; M Naito; T Arai; Y Hatano
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

4.  Risk factors in relation to postoperative complications in patients undergoing esophagectomy or gastrectomy for cancer.

Authors:  M Nishi; Y Hiramatsu; K Hioki; Y Kojima; T Sanada; H Yamanaka; M Yamamoto
Journal:  Ann Surg       Date:  1988-02       Impact factor: 12.969

5.  Pulmonary complications after subtotal oesophagectomy.

Authors:  M Nishi; Y Hiramatsu; K Hioki; T Hatano; M Yamamoto
Journal:  Br J Surg       Date:  1988-06       Impact factor: 6.939

  5 in total
  15 in total

1.  Surgical outcomes in esophageal cancer patients with tumor recurrence after curative esophagectomy.

Authors:  Chikara Kunisaki; Hirochika Makino; Ryo Takagawa; Naoto Yamamoto; Yasuhiko Nagano; Syoichi Fujii; Takashi Kosaka; Hidetaka A Ono; Yuichi Otsuka; Hirotoshi Akiyama; Yasushi Ichikawa; Hiroshi Shimada
Journal:  J Gastrointest Surg       Date:  2007-10-20       Impact factor: 3.452

2.  Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection.

Authors:  Hideaki Shimada; Shin-ichi Okazumi; Hisahiro Matsubara; Yoshihiro Nabeya; Tooru Shiratori; Takanori Shimizu; Kiyohiko Shuto; Hideki Hayashi; Takenori Ochiai
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

3.  Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.

Authors:  Yi Ren; Chang Su; Yang Zhou; Xiang Zhao; Cheng-Liang Yang; Yong-Yu Liu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 4.  Adjuvant therapies for cancer of the thoracic esophagus.

Authors:  T Nishihira; T Nakano; S Mori
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

5.  Extensive lymphadenectomy for thoracic esophageal carcinoma: a two-stage operation for high-risk patients.

Authors:  T Saito; K Shimoda; Y Shigemitsu; T Kinoshita; M Miyahara; M Kobayashi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

Review 6.  Combined modality therapy for esophageal cancer.

Authors:  Z Gamliel; M J Krasna
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

Review 7.  Three-field vs two-field lymph node dissection for esophageal cancer: a meta-analysis.

Authors:  Guo-Wei Ma; Dong-Rong Situ; Qi-Long Ma; Hao Long; Lan-Jun Zhang; Peng Lin; Tie-Hua Rong
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

8.  Squamous cell carcinoma of the esophagus: therapeutic dilemma.

Authors:  N K Altorki; L Girardi; D B Skinner
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

9.  Lymph node metastasis and recurrence in patients with a carcinoma of the thoracic esophagus who underwent three-field dissection.

Authors:  H Fujita; T Kakegawa; H Yamana; I Shima; H Tanaka; S Ikeda; S Nogami; Y Toh
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

10.  Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy.

Authors:  H Fujita; T Kakegawa; H Yamana; I Shima; Y Toh; Y Tomita; T Fujii; K Yamasaki; K Higaki; T Noake
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.